EM-T3Expert Opinion on Drug Safety2022-08-31第 22 卷第 4 期,343-349开放获取
Disproportionality analysis of adverse neurological and psychiatric reactions with the ChAdOx1 (Oxford-AstraZeneca) and BNT162b2 (Pfizer-BioNTech) COVID-19 vaccines in the United Kingdom